Health
PharmAust’s MPL and MPLS drug candidates again indicate antiviral activity in SARS-CoV2 – Small Caps
Further pre-clinical testing of PharmAust’s (ASX: PAA) monepantel (MPL) and monepantel sulphone (MPLS) drugs continues to demonstrate antiviral activity in cultured…
Further pre-clinical testing of PharmAusts (ASX: PAA) monepantel (MPL) and monepantel sulphone (MPLS) drugs continues to demonstrate antiviral activity in cultured cell infection models of SARS-CoV2 the virus causing the global COVID-19 pandemic.
Following positive earlier results in both primate and non-primate cell cultures, Leiden University Medical Centre has carried out more tests and generated data indicating both MPL and MPLS demonstrate antiviral activity in non-human primates.
This paves…
-
Noosa News19 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News17 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News18 hours agoGood character references restricted in rape cases in Queensland
-
Noosa News22 hours agoBrisbane Broncos star Reece Walsh says punching friend in face ‘not a good look’